Exacerbation of psychotic symptoms associated with gatifloxacin.
Reeves
Roy R
RR
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D004347:Drug Interactions; D024841:Fluoroquinolones / Q000009:adverse effects* / Q000627:therapeutic use; D000077734:Gatifloxacin; D005905:Glyburide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011605:Psychoses, Substance-Induced / Q000175:diagnosis*; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D018967:Risperidone; D005905:Glyburide